Krieger E, Kudryavtsev A, Sharashova E, Samodova O, Kontsevaya A, Postoev V
PLoS One. 2024; 19(10):e0311287.
PMID: 39392813
PMC: 11469529.
DOI: 10.1371/journal.pone.0311287.
Gach D, Beijers R, van Zeeland R, van Kampen-van den Boogaart V, Posthuma R, Schols A
Sci Rep. 2024; 14(1):16571.
PMID: 39019957
PMC: 11255309.
DOI: 10.1038/s41598-024-67314-0.
Malambo W, Chanda D, Besa L, Engamba D, Mwiinga L, Mwitumwa M
PLoS One. 2024; 19(7):e0306131.
PMID: 38954717
PMC: 11219000.
DOI: 10.1371/journal.pone.0306131.
Mohammadi Y, Ranjbaran J, Mamashli M, Marzuni H, Dashtgard A, Mohsenizadeh S
New Microbes New Infect. 2024; 60-61:101432.
PMID: 38800713
PMC: 11126988.
DOI: 10.1016/j.nmni.2024.101432.
Mitsikostas D, Caronna E, de Tommaso M, Deligianni C, Ekizoglu E, Bolay H
Eur J Neurol. 2024; 31(6):e16251.
PMID: 38415282
PMC: 11235838.
DOI: 10.1111/ene.16251.
Daily COVID-19 symptom assessment over 28 days - findings from a daily direct-to-patient registry of COVID-19 positive patients.
Brinkley E, Knuth K, Kwon T, Mack C, Leister-Tebbe H, Bao W
J Patient Rep Outcomes. 2023; 7(1):128.
PMID: 38060047
PMC: 10703747.
DOI: 10.1186/s41687-023-00668-7.
New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit.
Zakynthinos G, Tsolaki V, Oikonomou E, Vavouranakis M, Siasos G, Zakynthinos E
J Clin Med. 2023; 12(22).
PMID: 38002603
PMC: 10672690.
DOI: 10.3390/jcm12226989.
Infections associated with SARS-CoV-2 exploited via nanoformulated photodynamic therapy.
Pallavi P, Harini K, Elboughdiri N, Gowtham P, Girigoswami K, Girigoswami A
ADMET DMPK. 2023; 11(4):513-531.
PMID: 37937246
PMC: 10626507.
DOI: 10.5599/admet.1883.
Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19.
Verdiguel-Fernandez L, Arredondo-Hernandez R, Mejia-Estrada J, Ortiz A, Verdugo-Rodriguez A, Orduna P
BMC Infect Dis. 2023; 23(1):602.
PMID: 37715121
PMC: 10502992.
DOI: 10.1186/s12879-023-08573-6.
Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy.
Zhang Z, Tao W, Cheng D, Qin M, Fu J, Liu D
Front Immunol. 2023; 14:1197493.
PMID: 37638007
PMC: 10449257.
DOI: 10.3389/fimmu.2023.1197493.
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
Li D, Xu M, Hooper A, Rofail D, Mohammadi K, Chen Y
Sci Rep. 2023; 13(1):12784.
PMID: 37550377
PMC: 10406852.
DOI: 10.1038/s41598-023-39681-7.
The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting.
Schmidbauer L, Kirchberger I, Gosslau Y, Warm T, Hyhlik-Durr A, Linseisen J
J Neurol. 2023; 270(7):3294-3302.
PMID: 37219607
PMC: 10204671.
DOI: 10.1007/s00415-023-11752-9.
The effects of contemporaneous air pollution on COVID-19 morbidity and mortality.
Austin W, Carattini S, Gomez-Mahecha J, Pesko M
J Environ Econ Manage. 2023; 119:102815.
PMID: 37063946
PMC: 10073864.
DOI: 10.1016/j.jeem.2023.102815.
Association between initial symptoms and subsequent hospitalization in outpatients with COVID-19: A cohort study.
Zhabokritsky A, Daneman N, MacPhee S, Estrada-Codecido J, Santoro A, Kit Chan A
J Assoc Med Microbiol Infect Dis Can. 2022; 6(4):259-268.
PMID: 36338454
PMC: 9629262.
DOI: 10.3138/jammi-2021-0012.
Missing science: A scoping study of COVID-19 epidemiological data in the United States.
Bhatia R, Sledge I, Baral S
PLoS One. 2022; 17(10):e0248793.
PMID: 36223335
PMC: 9555641.
DOI: 10.1371/journal.pone.0248793.
Secondary bacterial infections are a leading factor triggering New Onset Atrial Fibrillation in intubated ICU Covid-19 ARDS patients.
Zakynthinos G, Tsolaki V, Karavidas N, Vazgiourakis V, Dimeas G, Mantzarlis K
J Infect Public Health. 2022; 15(7):766-772.
PMID: 35724437
PMC: 9385194.
DOI: 10.1016/j.jiph.2022.06.006.
Case-control study to identify risk factors for SARS-CoV-2 infection among university students in the northeastern USA.
Cummings K, Clarkberg M, Busche J, Travis A, Meredith G, Weisfuse I
Transbound Emerg Dis. 2022; 69(5):e2688-e2693.
PMID: 35687478
PMC: 9348057.
DOI: 10.1111/tbed.14619.
Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel.
Surapat B, Kobpetchyok W, Kiertiburanakul S, Arnuntasupakul V
Int J Clin Pract. 2022; 2022:3098527.
PMID: 35685498
PMC: 9159170.
DOI: 10.1155/2022/3098527.
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Schafer E, Scheer C, Salje K, Fritz A, Kohlmann T, Hubner N
Sci Rep. 2022; 12(1):7249.
PMID: 35508524
PMC: 9065670.
DOI: 10.1038/s41598-022-11103-0.
xsGastrointestinal symptoms are associated with a lower risk of hospitalization and mortality and Outcomes in COVID-19.
Delavari A, Asgari S, Alimohamadi Y, Vosoogh-Moghaddam A, Sadeghi A, SHahrousvand S
BMC Gastroenterol. 2022; 22(1):119.
PMID: 35272613
PMC: 8908290.
DOI: 10.1186/s12876-022-02190-4.